BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20219937)

  • 21. Identification and Herc5-mediated ISGylation of novel target proteins.
    Takeuchi T; Inoue S; Yokosawa H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):473-7. PubMed ID: 16884686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication.
    Hishiki T; Han Q; Arimoto K; Shimotohno K; Igarashi T; Vasudevan SG; Suzuki Y; Yamamoto N
    Biochem Biophys Res Commun; 2014 May; 448(1):95-100. PubMed ID: 24769207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.
    Kim KI; Giannakopoulos NV; Virgin HW; Zhang DE
    Mol Cell Biol; 2004 Nov; 24(21):9592-600. PubMed ID: 15485925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins.
    Zhao C; Sridharan H; Chen R; Baker DP; Wang S; Krug RM
    Nat Commun; 2016 Sep; 7():12754. PubMed ID: 27587337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection.
    Eduardo-Correia B; Martínez-Romero C; García-Sastre A; Guerra S
    J Virol; 2014 Feb; 88(4):2312-8. PubMed ID: 24257616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural insights into the species preference of the influenza B virus NS1 protein in ISG15 binding.
    Jiang Y; Wang X
    Protein Cell; 2019 Sep; 10(9):681-687. PubMed ID: 30519829
    [No Abstract]   [Full Text] [Related]  

  • 27. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase.
    Zou W; Zhang DE
    J Biol Chem; 2006 Feb; 281(7):3989-94. PubMed ID: 16352599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.
    Xu D; Zhang T; Xiao J; Zhu K; Wei R; Wu Z; Meng H; Li Y; Yuan J
    Autophagy; 2015 Apr; 11(4):617-28. PubMed ID: 25906440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mHERC6 is the essential ISG15 E3 ligase in the murine system.
    Ketscher L; Basters A; Prinz M; Knobeloch KP
    Biochem Biophys Res Commun; 2012 Jan; 417(1):135-40. PubMed ID: 22138649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-induced ISG15 pathway: an ongoing virus-host battle.
    Zhao C; Collins MN; Hsiang TY; Krug RM
    Trends Microbiol; 2013 Apr; 21(4):181-6. PubMed ID: 23414970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-Stimulated Gene 15 Conjugation Stimulates Hepatitis B Virus Production Independent of Type I Interferon Signaling Pathway
    Li Y; Li S; Duan X; Chen Y; Jiao B; Ye H; Yao M; Chen L
    Mediators Inflamm; 2016; 2016():7417648. PubMed ID: 27867263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy.
    Chen L; Li S; McGilvray I
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1427-31. PubMed ID: 21704181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A.
    Kim MJ; Yoo JY
    J Immunol; 2010 Oct; 185(7):4311-8. PubMed ID: 20810994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances in ubiquitin-like protein ISG15-mediated anti-viral response].
    Zhu ZX; Wei JC; Shi ZX; Wu KB; Ma ZY
    Bing Du Xue Bao; 2012 Jan; 28(1):78-83. PubMed ID: 22416355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The E3 ligase HERC5 promotes antimycobacterial responses in macrophages by ISGylating the phosphatase PTEN.
    Du X; Sheng J; Chen Y; He S; Yang Y; Huang Y; Fu Y; Lie L; Han Z; Zhu B; Liu H; Wen Q; Zhou X; Zhou C; Hu S; Ma L
    Sci Signal; 2023 Jun; 16(788):eabm1756. PubMed ID: 37279284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins.
    Swaim CD; Canadeo LA; Monte KJ; Khanna S; Lenschow DJ; Huibregtse JM
    Cell Rep; 2020 Jun; 31(11):107772. PubMed ID: 32553163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity.
    Takeuchi T; Yokosawa H
    Biochem Biophys Res Commun; 2005 Oct; 336(1):9-13. PubMed ID: 16112642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hepatitis C virus RNA replication by ISG15 does not require its conjugation to protein substrates by the HERC5 E3 ligase.
    Domingues P; Bamford CGG; Boutell C; McLauchlan J
    J Gen Virol; 2015 Nov; 96(11):3236-3242. PubMed ID: 26361997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.
    Yoo L; Yoon AR; Yun CO; Chung KC
    Cell Death Dis; 2018 Jan; 9(2):97. PubMed ID: 29367604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses.
    Wang W; Krug RM
    Virology; 1996 Sep; 223(1):41-50. PubMed ID: 8806538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.